Cladribine and oesophageal carcinoma Patient Reports February 12, 2012

Cladribine Side Effects Report #4957705-3
Cladribine side effect was reported by a Physician from UNITED STATES on Mar 17, 2006. Male patient, 56 years of age, weighting 262.0 lb, was diagnosed with multiple sclerosis  and was treated with Cladribine. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, metastases to liver, oesophageal carcinoma. Cladribine dosage: unknown. During the same period patient was treated with NOVANTRONE, COPAXONE. Patient was hospitalized. Patient recovered.

Cladribine Side Effects Report #5192269-3
Cladribine side effect was reported by a Physician from UNITED STATES on Dec 22, 2006. Male patient, weighting 262.0 lb, was diagnosed with multiple sclerosis  and was treated with Cladribine. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, metastases to bone, metastases to liver, oesophageal carcinoma. Cladribine dosage: unknown. During the same period patient was treated with NOVANTRONE, COPAXONE, ATORVASTATIN, METFORMIN, LISINOPRIL, ASPIRIN, AMITRIPTYLINE. Patient was hospitalized. Patient died on 09/24/2006.